Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine with short-term low-dose olanzapine for comorbid anxiety and depression
ChiCTR-TRC-11001748Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluoxetine and olanzapine in anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale and 1 more. Started Mar 2010; status: completed.
02
Drugs
fluoxetineolanzapine
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001748.